Search

Your search keyword '"Alisha Holtzhausen"' showing total 11 results

Search Constraints

Start Over You searched for: Author "Alisha Holtzhausen" Remove constraint Author: "Alisha Holtzhausen" Topic business.industry Remove constraint Topic: business.industry
11 results on '"Alisha Holtzhausen"'

Search Results

1. Pharmacological Wnt ligand inhibition overcomes key tumor-mediated resistance pathways to anti-PD-1 immunotherapy

2. Factor XIIIA—expressing inflammatory monocytes promote lung squamous cancer through fibrin cross-linking

3. A tumor-intrinsic PD-L1/NLRP3 inflammasome signaling pathway drives resistance to anti-PD-1 immunotherapy

4. Stromal Fibroblasts Mediate Anti-PD-1 Resistance via MMP-9 and Dictate TGFβ Inhibitor Sequencing in Melanoma

5. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

6. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

7. Targeting the Wnt5a-β-catenin pathway in the melanoma microenvironment to augment checkpoint inhibitor immunotherapy

8. Combinatorial TGF-β signaling blockade and anti-CTLA-4 antibody immunotherapy in a murine BRAFV600E-PTEN-/- transgenic model of melanoma

9. Melanoma-derived Wnt5a conditions dendritic cells to promote regulatory T cell differentiation via the upregulation of indoleamine 2,3-dioxygenase: novel pharmacological strategies for augmenting immunotherapy efficacy

10. Role of the Wnt-β-catenin signaling pathway in melanoma-mediated dendritic cell tolerization

11. Effect of the loss of the type III TGFβ receptor during tumor progression on tumor microenvironment: Preclinical development of TGFβ inhibition and TGFβ-related biomarkers to enhance immunotherapy efficacy

Catalog

Books, media, physical & digital resources